PURPOSE: Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome surveillance data are critical for monitoring epidemic trends, but they can mask dynamic subepidemics, especially in vulnerable populations that underuse HIV testing. In this case study, we describe community-based epidemiologic data among injection drug users (IDUs) and female sex workers (FSWs) in two northern Mexico-U.S. border states that identified an emerging HIV epidemic and generated a policy response. METHODS: We draw from quantitative and qualitative cross-sectional and prospective epidemiologic studies and behavioral intervention studies among IDUs and FSWs in Tijuana, Baja California, and Ciudad Juarez, Chihuahua. RESULTS: The recognition that the HIV epidemic on Mexico's northern border was already well established in subgroups in whom it had been presumed to be insignificant was met with calls for action and enhanced prevention efforts from researchers, nongovernmental organizations, and policy makers. CONCLUSIONS: Successful policies and program outcomes included expansion of needle-exchange programs, a nationwide mobile HIV prevention program targeting marginalized populations, a successful funding bid from the Global Fund for HIV, TB, and Malaria to scale up targeted HIV-prevention programs, and the establishment of bi-national training programs on prevention of HIV and substance use. We discuss how epidemiologic data informed HIV prevention policies and suggest how other countries may learn from Mexico's experience.
PURPOSE:Humanimmunodeficiency virus (HIV)/acquired immunodeficiency syndrome surveillance data are critical for monitoring epidemic trends, but they can mask dynamic subepidemics, especially in vulnerable populations that underuse HIV testing. In this case study, we describe community-based epidemiologic data among injection drug users (IDUs) and female sex workers (FSWs) in two northern Mexico-U.S. border states that identified an emerging HIV epidemic and generated a policy response. METHODS: We draw from quantitative and qualitative cross-sectional and prospective epidemiologic studies and behavioral intervention studies among IDUs and FSWs in Tijuana, Baja California, and Ciudad Juarez, Chihuahua. RESULTS: The recognition that the HIV epidemic on Mexico's northern border was already well established in subgroups in whom it had been presumed to be insignificant was met with calls for action and enhanced prevention efforts from researchers, nongovernmental organizations, and policy makers. CONCLUSIONS: Successful policies and program outcomes included expansion of needle-exchange programs, a nationwide mobile HIV prevention program targeting marginalized populations, a successful funding bid from the Global Fund for HIV, TB, and Malaria to scale up targeted HIV-prevention programs, and the establishment of bi-national training programs on prevention of HIV and substance use. We discuss how epidemiologic data informed HIV prevention policies and suggest how other countries may learn from Mexico's experience.
Authors: Angela M Robertson; M Gudelia Rangel; Remedios Lozada; Alicia Vera; Victoria D Ojeda Journal: Drug Alcohol Depend Date: 2011-08-10 Impact factor: 4.492
Authors: Fátima A Muñoz; Robin A Pollini; María Luisa Zúñiga; Steffanie A Strathdee; Remedios Lozada; Gustavo A Martínez; Ana M Valles-Medina; Nicole Sirotin; Thomas L Patterson Journal: AIDS Educ Prev Date: 2010-10
Authors: Laura B Moyer; Kimberley C Brouwer; Stephanie K Brodine; Rebeca Ramos; Remedios Lozada; Michelle Firestone Cruz; Carlos Magis-Rodriguez; Steffanie A Strathdee Journal: Drug Alcohol Rev Date: 2008-01
Authors: Louisa Degenhardt; Bradley Mathers; Mauro Guarinieri; Samiran Panda; Benjamin Phillips; Steffanie A Strathdee; Mark Tyndall; Lucas Wiessing; Alex Wodak; John Howard Journal: Int J Drug Policy Date: 2010-02-01
Authors: Jennifer Syvertsen; Robin A Pollini; Remedios Lozada; Alicia Vera; Gudelia Rangel; Steffanie A Strathdee Journal: Int J Drug Policy Date: 2010-08-25
Authors: Steffanie A Strathdee; Remedios Lozada; Robin A Pollini; Kimberly C Brouwer; Andrea Mantsios; Daniela A Abramovitz; Tim Rhodes; Carl A Latkin; Oralia Loza; Jorge Alvelais; Carlos Magis-Rodriguez; Thomas L Patterson Journal: J Acquir Immune Defic Syndr Date: 2008-03-01 Impact factor: 3.731
Authors: Brooke S West; Daniela Abramovitz; Hugo Staines; Alicia Vera; Thomas L Patterson; Steffanie A Strathdee Journal: J Urban Health Date: 2016-02 Impact factor: 3.671
Authors: Laramie R Smith; Thomas L Patterson; Carlos Magis-Rodriguez; Victoria D Ojeda; Jose Luis Burgos; Sarah A Rojas; María Luisa Zúñiga; Steffanie A Strathdee Journal: AIDS Behav Date: 2016-05
Authors: Argentina E Servin; Kimberly C Brouwer; Leah Gordon; Teresita Rocha-Jimenez; Hugo Staines; Ricardo B Vera-Monroy; Steffanie A Strathdee; Jay G Silverman Journal: J Appl Res Child Date: 2015
Authors: S S Shin; R Laniado-Laborin; P G Moreno; T E Novotny; S A Strathdee; R S Garfein Journal: Int J Tuberc Lung Dis Date: 2013-11 Impact factor: 2.373
Authors: Argentina E Servin; Elizabeth Reed; Kimberly C Brouwer; Carlos Magis-Rodriguez; Sabrina Boyce; Steffanie A Strathdee; Jay G Silverman Journal: Sex Transm Dis Date: 2017-08 Impact factor: 2.830
Authors: Ana P Martinez-Donate; Melbourne F Hovell; Maria Gudelia Rangel; Xiao Zhang; Carol L Sipan; Carlos Magis-Rodriguez; J Eduardo Gonzalez-Fagoaga Journal: Am J Public Health Date: 2015-01-20 Impact factor: 9.308
Authors: David Goodman-Meza; Maria Elena Medina-Mora; Carlos Magis-Rodríguez; Raphael J Landovitz; Steve Shoptaw; Dan Werb Journal: Am J Public Health Date: 2018-11-29 Impact factor: 9.308
Authors: Erick G Guerrero; Jorge Ameth Villatoro; Yinfei Kong; Marycarmen Bustos Gamiño; William A Vega; Maria Elena Medina Mora Journal: Int J Drug Policy Date: 2014-04-18